This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nippon Chemiphar Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Takaichi Hamano: Innovator in Diabetes Treatment
Introduction
Takaichi Hamano is a notable inventor based in Misato, Japan. He has made significant contributions to the field of diabetes treatment through his innovative work. His expertise and dedication have led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Takaichi Hamano holds a patent for a GPR119 agonist. This invention is a cyclic amine derivative represented by the formula (II). It is specifically designed to be used as an agent for treating diabetes, showcasing his commitment to improving health outcomes.
Career Highlights
Hamano is associated with Nippon Chemiphar Co., Ltd., where he continues to work on advancements in pharmaceutical research. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his coworkers include Tsuyoshi Endo and Rie Takahashi. Their collective efforts contribute to the innovative environment at Nippon Chemiphar Co., Ltd.
Conclusion
Takaichi Hamano's work exemplifies the impact of innovation in the medical field, particularly in diabetes treatment. His patent reflects a significant advancement that could benefit many individuals suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile